2022
Corticosteroid-Induced Glaucoma
Liu J, Arrigg C. Corticosteroid-Induced Glaucoma. 2022, 2541-2560. DOI: 10.1007/978-3-030-42634-7_183.Peer-Reviewed Original ResearchPrimary open-angle glaucomaCorticosteroid-induced glaucomaOpen-angle glaucomaCorticosteroid useOcular hypertensionAngle glaucomaCorticosteroid-induced ocular hypertensionIntraocular pressure elevationEffect of corticosteroidsRoute of administrationSecondary glaucomaClinical coursePressure elevationSystemic disordersRisk factorsFamily historyEffective treatmentOutflow facilityGlaucomaOcular tissuesTrabecular meshworkCareful monitoringIntracellular alterationsHypertensionCorticosteroids
2020
Corticosteroid-Induced Glaucoma
Liu J, Arrigg C. Corticosteroid-Induced Glaucoma. 2020, 1-20. DOI: 10.1007/978-3-319-90495-5_183-1.ChaptersPrimary open-angle glaucomaCorticosteroid-induced glaucomaOpen-angle glaucomaCorticosteroid useOcular hypertensionAngle glaucomaCorticosteroid-induced ocular hypertensionIntraocular pressure elevationEffect of corticosteroidsRoute of administrationSecondary glaucomaClinical coursePressure elevationSystemic disordersRisk factorsFamily historyEffective treatmentOutflow facilityGlaucomaOcular tissuesTrabecular meshworkCareful monitoringIntracellular alterationsHypertensionCorticosteroidsHerbal Medicines in Glaucoma Treatment.
Ige M, Liu J. Herbal Medicines in Glaucoma Treatment. The Yale Journal Of Biology And Medicine 2020, 93: 347-353. PMID: 32607093, PMCID: PMC7309662.Peer-Reviewed Original ResearchConceptsCourse of glaucomaIntraocular pressureGlaucoma patientsGlaucoma treatmentRetinal ganglion cell deathHerbal medicineMedical marijuanaGanglion cell deathStandard therapeutic agentsSignificant adverse effectsCurrent standardGinkgo bilobaSurgical therapyGlaucoma managementIrreversible blindnessGlaucomaAlternative medicineLarger studyHerbal remediesTherapeutic agentsAddictive potentialAdverse effectsLonger durationPatientsShort duration
2017
Epigenetics and Signaling Pathways in Glaucoma
Gauthier AC, Liu J. Epigenetics and Signaling Pathways in Glaucoma. BioMed Research International 2017, 2017: 5712341. PMID: 28210622, PMCID: PMC5292191, DOI: 10.1155/2017/5712341.Peer-Reviewed Original ResearchConceptsPotential new therapeutic targetGeneration of fibrosisNovel therapeutic agentsNew therapeutic targetsAqueous humor drainageProapoptotic gene expressionRetinal neuronsIrreversible blindnessCommon causeHuman trialsTherapeutic targetAnimal modelsTrabecular meshworkTherapeutic agentsNeurodegenerative diseasesProsurvival factorBcl-2Rho-kinaseGlaucomaSignaling pathwaysPathway membersMAP kinaseGene expressionPathwayPreliminary success
2016
The Application of a Contact Lens Sensor in Detecting 24‐Hour Intraocular Pressure‐Related Patterns
Xu SC, Gauthier AC, Liu J. The Application of a Contact Lens Sensor in Detecting 24‐Hour Intraocular Pressure‐Related Patterns. Journal Of Ophthalmology 2016, 2016: 4727423. PMID: 27525110, PMCID: PMC4976175, DOI: 10.1155/2016/4727423.Peer-Reviewed Original ResearchContact lens sensorDisease progressionPrimary angle-closure glaucomaPrimary open-angle glaucomaCurrent glaucoma managementIOP-lowering interventionsSingle IOP measurementDisease statesThyroid eye diseaseAngle-closure glaucomaNormal-tension glaucomaOpen-angle glaucomaVisual field progressionIntraocular pressure fluctuationCause of blindnessOcular hypertensionClinic hoursClinical variablesGlaucoma managementField progressionDisease advancementEye diseaseIOP measurementsGlaucomaIOPTrends in ophthalmology resident surgical experience from 2009 to 2015
Chadha N, Liu J, Maslin JS, Teng CC. Trends in ophthalmology resident surgical experience from 2009 to 2015. Clinical Ophthalmology 2016, Volume 10: 1205-1208. PMID: 27418803, PMCID: PMC4935003, DOI: 10.2147/opth.s106293.Peer-Reviewed Original ResearchResident surgical experienceSurgical experienceCataract surgeryPhacoemulsification cataract surgerySurgical case logsArea of cataractShunt surgeryResident experiencePrimary surgeonRetinal photocoagulationDatabase studySurgical casesSurgerySurgical training programsOphthalmology residentsGlaucomaCase logsCataractTherapeutic developmentRetinaPediatricsTraumaAccreditation CouncilCorneaTraining programNeurodegeneration and Neuroprotection in Glaucoma.
Gauthier AC, Liu J. Neurodegeneration and Neuroprotection in Glaucoma. The Yale Journal Of Biology And Medicine 2016, 89: 73-9. PMID: 27505018, PMCID: PMC4797839.Peer-Reviewed Original ResearchConceptsCentral nervous system degenerative disorderOptic nerve degenerationRetinal ganglion cellsLateral geniculate nucleusAdenosine receptor antagonistIntraocular pressureNerve degenerationNeurotrophic factorReceptor antagonistGanglion cellsGlaucoma progressionDisease progressionIrreversible blindnessGeniculate nucleusNew therapiesVisual cortexDegenerative disordersAxonal transportCell therapyGlaucomaOxidative stressTherapyDiseaseNeuroprotectionNeurodegeneration
2015
Marijuana for Glaucoma: A Recipe for Disaster or Treatment?
Sun X, Xu CS, Chadha N, Chen A, Liu J. Marijuana for Glaucoma: A Recipe for Disaster or Treatment? The Yale Journal Of Biology And Medicine 2015, 88: 265-9. PMID: 26339209, PMCID: PMC4553646.Peer-Reviewed Original ResearchConceptsCannabis use disorderIntraocular pressureGlaucoma patientsGlaucoma treatmentAdverse effectsMost glaucoma patientsLower intraocular pressurePsychological adverse effectsTreatment of glaucomaNumerous adverse effectsSignificant adverse effectsWithdrawal symptomsPossible progressionUse disordersUse of marijuanaSubstance abuseMedical marijuanaRare circumstancesFurther studiesTreatmentPatientsGlaucomaCannabinoid moleculesMarijuanaDeleterious effects